Chicago Partners Investment Group LLC Solid Biosciences Inc. Transaction History

Chicago Partners Investment Group LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 20, 2022	SELL	$0.74 - $1.79 $14,054 - $33,997	-18,993 Closed	0 $0
Q4 2021 Feb 15, 2022	SELL	$1.69 - $2.46 $7,726 - $11,247	-4,572 Reduced 19.4%	18,993 $20,000
Q3 2021 Nov 12, 2021	SELL	$2.38 - $3.77 $3,815 - $6,043	-1,603 Reduced 6.37%	23,565 $56,000
Q2 2021 Aug 02, 2021	BUY	$3.49 - $5.51 $16,427 - $25,935	4,707 Added 23.0%	25,168 $70,000
Q1 2021 Apr 28, 2021	BUY	$5.37 - $10.72 $109,875 - $219,341	20,461 New	20,461 $107,000

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $25.1M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Chicago Partners Investment Group LLC, based on Form 13F filings with the SEC.

Stay updated on Chicago Partners Investment Group LLC with notifications on news.